J&J, other drugmakers go to trial in California in $50 billion case over 'deadly legacy' of opioids
Updated J&J, other drugmakers go to trial in California in $50 billion case over 'deadly legacy' of opioids 3 Min Read (Reuters) -Four drugmakers helped cause the deadly U.S. opioid epidemic by deceptively marketing their drugs and downplaying their addictive risks, a lawyer for several California counties argued on Monday at the start of a multibillion-dollar trial. Slideshow ( 5 images ) Those counties accuse Johnson & Johnson, Teva Pharmaceutical Industries Ltd, Endo International Plc and AbbVie Inc’s Allergan unit of fueling a drug crisis that according to the U.S. government resulted ...